<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref46">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lin</surname>
    <given-names>C. -W.</given-names>
   </name>
   <name>
    <surname>Tsai</surname>
    <given-names>C. -H.</given-names>
   </name>
   <name>
    <surname>Tsai</surname>
    <given-names>F. -J.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>P. J.</given-names>
   </name>
   <name>
    <surname>Lai</surname>
    <given-names>C. -C.</given-names>
   </name>
   <name>
    <surname>Wan</surname>
    <given-names>L.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2004</year>). 
  <article-title>Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: basis for the 
   <italic>in vitro</italic> screening of anti-SARS drugs
  </article-title>. 
  <source>FEBS Lett.</source>
  <volume>574</volume>, 
  <fpage>131</fpage>â€“
  <lpage>137</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.febslet.2004.08.017</pub-id>, PMID: 
  <?supplied-pmid 15358553?>
  <pub-id pub-id-type="pmid">15358553</pub-id>
 </mixed-citation>
</ref>
